Trial
NCT01445821
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwestern University
Collaborators
—
Condition
Scleroderma, Systemic
Intervention
Peripheral Blood Stem Cells
Why stopped
Developed a better regimen: DIAD. Cast. 2018 NCT03593902
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-23